Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide.

Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide. Abstract Text:

    t yamazakiT Yamazaki,m hayashiM Hayashi,a komatsuzakiA Komatsuzaki,

    In 1974 (6), 6 patients with incapacitating unilateral Meniere's disease were given an empiric treatment with intratympanic gentamicin sulfate via the eustachian tube using a catheter with a small side-branch. These patients showed excellent results, gaining relief from vertigo over a 13-year period. Since 1980 (7. 8), we have treated patients suffering from Menière's disease with isosorbide. When the patients could not be controlled by this therapy, isosorbide was given in addition to intratympanic gentamicin therapy using a tubal catheter. Of 75 patients with Menière's disease who received gentamicin and isosorbide therapy, 41 could be evaluated by the classification of the American Academy of Opthalmology and Otolaryngology (AAOO) in 1987 (9). Three of these patients suffered from repeated attacks of vertigo for 2 years. However, all of them could be easily controlled by additional intratympanic gentamicin or isosorbide therapy on an out-patient basis. Thereafter, of a further 40 patients with incapacitating Menière's disease who received gentamicin and isosorbide therapy, 15 could be evaluated by the AAOO classification. In summary, of the 115 patients with incapacitating Menière's disease treated with intratympanic gentamicin after isosorbide treatment, 56 could be evaluated by the AAOO criteria from 1987 to 1990. These patients ranged in age from 21 to 79 years. Vertigo improved in 80% of the patients: 19 patients (34%) were group A. 22 patients (39%) were group B, 4 patients 7%) were group C and 11 patients (20%) were group D, of whom 9 patients required subsequent endolymphatic-mastoid shunt operations. This treatment also effectively controlled patients with bilateral Menière's disease.

    Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide. Publishing Authors By Initials

    t yamazakiT Yamazaki,m hayashiM Hayashi,a komatsuzakiA Komatsuzaki,

    For similar otorhinolaryngologic diseases: ear diseases: labyrinth diseases: vestibular diseases research abstracts see: otorhinolaryngologic diseases: ear diseases: labyrinth diseases: vestibular diseases research

    PUBMED ID PMID:

    MEDLINE DATE:

    Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Acta oto-laryngologica. Supplementum

    VOLUME: 481

    Page Numbers: 613-6

    Journal Abbreviation:

    ISSN: 0365-5237

    DAY: 13

    MONTH: 02

    YEAR: 1991

    Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370355

    Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide. Keywords Mesh Terms:

    KEYWORDS: Vestibular Diseases

    MESH TERMS: physiopathology

    Chemical & Substance for Abstract: Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide. Information

    Substance Name: Isosorbide Dinitrate

    Registry Number: 87-33-2

    Grant and Affiliation Information for Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide.

    AFFILIATION: Department of Neurotology, Sapporo City General Hospital, Japan.

    Country: SWEDEN

    SWEDEN Research PublicationSWEDEN Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Acta Otolaryngol Suppl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News